​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $672.00, with a high of $715.00 and a low of $605.00. This represents a 0.04% increase from the last price of $671.75.

$350 $430 $510 $590 $670 $750 High: $715 Avg: $672 Low: $605 Last Closed Price: $671.75

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 1 Strong Buy (4.55%), 19 Buy (86.36%), 2 Hold (9.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 2 19 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE0.04%
SectorHealthcare Stocks 25.00%
IndustryBiotech Stocks 63.52%

Price Target Trends

1M3M12M
# Anlaysts1115
Avg Price Target$696.00$696.00$536.27
Last Closing Price$671.75$671.75$671.75
Upside/Downside3.61%3.61%-20.17%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 257132--22
Jan, 257132--22
Dec, 247142--23
Nov, 247143--24
Oct, 249144--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 14, 2025Jason ButlerJMP Securities$696.00$648.627.30%3.61%
Nov 05, 2024George FarmerScotiabank$715.00$602.4718.68%6.44%
Oct 10, 2024Danielle BrillRaymond James$605.00$520.5216.23%-9.94%
Jul 29, 2024Joel BeattyRobert W. Baird$515.00$495.923.85%-23.33%
Jul 26, 2024Douglas TsaoH.C. Wainwright$533.00$492.078.32%-20.66%
Jul 23, 2024Leland GershellOppenheimer$546.00$461.0118.44%-18.72%
Jul 22, 2024Joon LeeTruist Financial$540.00$461.0117.13%-19.61%
Jul 12, 2024Gavin Clark-GartnerEvercore ISI$533.00$461.7215.44%-20.66%
Jun 26, 2024Douglas TsaoH.C. Wainwright$490.00$451.558.52%-27.06%
Jun 24, 2024Joon LeeTruist Financial$480.00$441.168.80%-28.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 14, 2025H.C. WainwrightBuyBuyhold
Jan 14, 2025JMP SecuritiesOutperformOutperformhold
Dec 19, 2024Wells FargoOverweightOverweighthold
Dec 09, 2024Piper SandlerOverweightOverweighthold
Nov 22, 2024JefferiesBuyBuyhold
Nov 11, 2024Wolfe ResearchOutperformupgrade
Nov 05, 2024ScotiabankSector PerformOutperformupgrade
Nov 01, 2024Leerink PartnersOutperformOutperformhold
Nov 01, 2024William BlairOutperformOutperformupgrade
Oct 17, 2024Wells FargoBuyBuyhold

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.01$-7.99$-13.05$-5.16-----
Avg Forecast$-10.20$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-12.34$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Low Forecast$-9.02$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Surprise %-99.90%15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$44.80M$497.28M$410.75M$1.23B-----
Avg Forecast$71.20M$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$64.86M$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Low Forecast$82.66M$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Surprise %-37.08%-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-650.55M$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-583.25M$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-705.29M$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Low Forecast$-515.74M$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Surprise %11.54%3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 19 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 22 Wall Street analysts, averages $672 over the next 12 months. The price target range spans from $605 at the low end to $715 at the high end, suggesting a potential 0.04% change from the previous closing price of $671.75.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 0.04% upside, underperforming the average forecast for the healthcare stocks sector (25.00%) and underperforming the biotech stocks industry (63.52%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • February 2025: 31.82% Strong Buy, 59.09% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 31.82% Strong Buy, 59.09% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 30.43% Strong Buy, 60.87% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December is $2.19 for 2024, a -142.44% decrease from the reported $-5.16 in 2023. The prediction for 2025 is $9.99, $18.54 for 2026, $26.94 for 2027, and $34.47 for 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December is $2.17B for 2024, a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

For its fiscal year ending in December, argenx SE's average annual net income forecast is $118.49M for 2024, reflecting a -140.16% decrease from the reported $-295M in 2023. The projection for 2025 is $647.04M, $1.3B for 2026, $1.79B for 2027, and $1.97B for 2028.